Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of zinc nanoparticles on transmission of HPV infection in men with genital warts
IRCT20190624043991N21Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2024
- Modality
- Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of zinc oxide nanoparticles in anogenital warts and human papillomavirus infection, sponsored by Tehran University of Medical Sciences. Started Mar 2024; status: completed.
02
Drugs
zinc oxide nanoparticles
03
Conditions
anogenital wartshuman papillomavirus infection
Beyond the preview
Go deeper on IRCT20190624043991N21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190624043991N21.